Our world-class, multidisciplinary team of psychedelic, drug development, commercialisation and digital experts are united by their determination to help people living with neuropsychiatric disorders.
Dr. Robin L Carhart-Harris
Professor Matthew W Johnson PhD
Other investors include investment entities (e.g. funds and family offices) and individuals.
Links to other websites do not imply affiliation or endorsement. Beckley Psytech does not control and is not responsible for their content.